Skip Navigation


Rheumatology Advance Access originally published online on February 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/563    most recent
keg191v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zeuner, R. A.
Right arrow Articles by Verthelyi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeuner, R. A.
Right arrow Articles by Verthelyi, D.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 563-569
© 2003 British Society for Rheumatology

Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides

R. A. Zeuner1,3, D. M. Klinman1,, G. Illei2, C. Yarboro2, K. J. Ishii1, M. Gursel1 and D. Verthelyi1

1 Center for Biologics Evaluation and Research/Food and Drug Administration, Bethesda, Maryland, USA,
2 NIAMS, National Institutes of Health, Bethesda, Maryland, USA and
3 II. Medical Clinic, University of Kiel, Germany

Objectives. Increased levels of hypomethylated CpG-containing DNA in sera from patients with systemic lupus erythematosus (SLE) may contribute to the initiation and/or perpetuation of the disease. This study characterizes the in vitro response of peripheral blood mononuclear cells (PBMC) from SLE patients to CpG DNA.

Methods. Secretion of cytokines and IgM, cell proliferation and up-regulation of co-stimulatory molecules were evaluated in PBMC from SLE patients (n=24) and normal controls (n=24) after stimulation with synthetic oligodeoxynucleotides (ODN) containing CpG motifs.

Results. Up-regulation of co-stimulatory molecules and the secretion of interferon-{alpha} and interleukin-6 (IL-6) in response to CpG ODN was significantly reduced in monocytes and dendritic cells from SLE patients. Secretion of interferon-{gamma} by natural killer (NK) cells was also reduced. In contrast, the IgM and IL-10 response of B cells to CpG ODN was normal.

Conclusion. Monocytes, dendritic cells and NK cells from SLE patients respond abnormally to CpG ODN stimulation, which may contribute to the cytokine imbalance observed in SLE.

KEY WORDS: SLE, Innate immune system, CpG oligodeoxynucleotide, Toll-like receptor, Dendritic cells.

Correspondence to: D. M. Klinman, Section of Retroviral Research, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bldg 29A, Room 3D10, Bethesda, Maryland 20892, USA. E-mail: klinman{at}cber.fda.gov


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
K Hasegawa and T Hayashi
Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB xNZWF1 mice
Lupus, November 1, 2003; 12(11): 838 - 845.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.